T1	Drug	94	119	cholinesterase inhibitors	UMLS:C0008425	Cholinesterase Inhibitors
T46	Disease	123	142	Alzheimer’s disease	UMLS:C0002395	Alzheimer's Disease
T75	Phenotype	0	19	Hippocampal atrophy	UMLS:C3280737	Hippocampal atrophy (1 patient)
T76	Phenotype	28	48	white-matter changes	UMLS:C1833300	White matter changes
T2	Drug	230	262	cholinesterase inhibitors (ChEI)	UMLS:C0008425	Cholinesterase Inhibitors
T47	Disease	311	330	Alzheimer’s disease	UMLS:C0002395	Alzheimer's Disease
T77	Phenotype	342	376	medial temporal lobe atrophy (MTA)	null	null
T78	Phenotype	381	413	white matter hyperintensity (WMH	UMLS:C2938912	White matter hyperintensities
T48	Disease	446	487	very mild to moderate Alzheimer’s disease	UMLS:C0002395	Alzheimer's Disease
T79	Drug	497	522	cholinesterase inhibitors	UMLS:C0008425	Cholinesterase Inhibitors
T80	Measure	628	658	Clinical Dementia Rating (CDR)	UMLS:C0451074	Clinical dementia rating scale
T81	Measure	660	701	Taiwanese Mental State Examination (TMSE)	null	null
T82	Phenotype	726	729	MTA	null	null
T83	Phenotype	734	737	WMH	UMLS:C2938912	White matter hyperintensities
T84	Measure	816	820	TMSE	null	null
T85	Measure	917	921	TMSE	null	null
T86	Phenotype	968	971	MTA	null	null
T87	Phenotype	1144	1147	WMH	UMLS:C2938912	White matter hyperintensities
T11	Drug	1277	1281	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T12	Drug	1375	1387	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T88	AgeGroup	1241	1252	younger age	null	null
T89	Phenotype	1312	1315	MTA	null	null
T90	Measure	1356	1360	TMSE	null	null
T13	Drug	1425	1429	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T49	Disease	1489	1500	Alzheimer’s	UMLS:C0002395	Alzheimer's Disease
T91	AgeGroup	1389	1400	Younger age	null	null
T92	Phenotype	1459	1462	MTA	null	null
T14	Drug	1576	1580	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T93	Phenotype	1512	1515	WMH	UMLS:C2938912	White matter hyperintensities
T50	Disease	1730	1771	mild to moderate Alzheimer’s disease (AD)	UMLS:C0002395	Alzheimer's Disease
T94	Drug	1582	1615	Cholinesterase inhibitors (ChEIs)	UMLS:C0008425	Cholinesterase Inhibitors
T95	Phenotype	1692	1712	cognitive impairment	HPO:HP:0100543	Cognitive impairment
T96	Drug	1913	1918	ChEIs	UMLS:C0008425	Cholinesterase Inhibitors
T54	Disease	1941	1949	early AD	UMLS:C0750901	Alzheimer Disease, Early Onset
T15	Drug	2089	2101	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T55	Disease	2293	2295	AD	UMLS:C0002395	Alzheimer's Disease
T56	Disease	2462	2464	AD	UMLS:C0002395	Alzheimer's Disease
T58	Disease	2427	2458	mild cognitive impairment (MCI)	UMLS:C1270972	Mild cognitive disorder
T97	Phenotype	2348	2377	medial temporal atrophy (MTA)	null	null
T16	Drug	2619	2623	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T98	Phenotype	2573	2576	MTA	null	null
T99	Phenotype	2692	2725	white matter hyperintensity (WMH)	UMLS:C2938912	White matter hyperintensities
T100	Phenotype	2833	2854	cognitive dysfunction	HPO:HP:0100543	Cognitive impairment
T17	Drug	2912	2916	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T57	Disease	2888	2890	AD	UMLS:C0002395	Alzheimer's Disease
T101	Demographic	2868	2874	Taiwan	UMLS:C0039260	Taiwan
T18	Drug	3057	3061	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T51	Disease	3192	3203	Alzheimer’s	UMLS:C0002395	Alzheimer's Disease
T102	Phenotype	2990	2993	WMH	UMLS:C2938912	White matter hyperintensities
T59	Disease	3304	3306	AD	UMLS:C0002395	Alzheimer's Disease
T103	Phenotype	3269	3272	WMH	UMLS:C2938912	White matter hyperintensities
T19	Drug	3403	3415	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T104	Phenotype	3357	3360	WMH	UMLS:C2938912	White matter hyperintensities
T20	Drug	3555	3567	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T60	Disease	3530	3532	AD	UMLS:C0002395	Alzheimer's Disease
T10	Drug	3687	3719	cholinesterase inhibitor therapy	UMLS:C0008425	Cholinesterase Inhibitors
T61	Disease	3596	3620	very mild to moderate AD	UMLS:C0002395	Alzheimer's Disease
T105	Measure	3622	3652	Clinical Dementia Rating (CDR)	UMLS:C0451074	Clinical dementia rating scale
T106	ScaleMin	3660	3663	0.5	null	null
T107	ScaleMax	3666	3667	2	null	null
T62	Disease	3851	3853	AD	UMLS:C0002395	Alzheimer's Disease
T63	Disease	4031	4042	AD dementia	UMLS:C0002395	Alzheimer's Disease
T8	Drug	4255	4279	cholinesterase inhibitor	UMLS:C0008425	Cholinesterase Inhibitors
T108	Measure	4385	4431	TMSE (Taiwanese Mini-Mental State Examination)	null	null
T109	Measure	4452	4455	CDR	UMLS:C0451074	Clinical dementia rating scale
T9	Drug	4590	4614	cholinesterase inhibitor	UMLS:C0008425	Cholinesterase Inhibitors
T110	Measure	4493	4497	TMSE	null	null
T111	Measure	4502	4505	CDR	UMLS:C0451074	Clinical dementia rating scale
T21	Drug	4846	4850	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T112	Drug	4856	4861	ChEIs	UMLS:C0008425	Cholinesterase Inhibitors
T113	Drug	4891	4900	donepezil	DrugBank:DB00843	Donepezil
T114	Drug	4918	4930	rivastigmine	DrugBank:DB00989	Rivastigmine
T115	Drug	4951	4962	galantamine	DrugBank:DB00674	Galantamine
T22	Drug	5158	5162	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T116	Drug	4994	4999	ChEIs	UMLS:C0008425	Cholinesterase Inhibitors
T117	Drug	5062	5071	donepezil	DrugBank:DB00843	Donepezil
T118	Drug	5084	5096	rivastigmine	DrugBank:DB00989	Rivastigmine
T119	Drug	5112	5123	galantamine	DrugBank:DB00674	Galantamine
T120	Demographic	5380	5383	USA	UMLS:C0041703	United States
T121	Demographic	5461	5468	Germany	UMLS:C0017480	Germany
T122	Phenotype	6184	6187	MTA	null	null
T123	Phenotype	6395	6398	MTA	null	null
T124	Phenotype	6434	6462	medial temporal lobe atrophy	null	null
T125	Phenotype	6496	6499	MTA	null	null
T126	Phenotype	6548	6551	MTA	null	null
T127	Phenotype	6613	6616	MTA	null	null
T128	Phenotype	6634	6637	MTA	null	null
T129	AgeGroup	6684	6706	75-years-old and under	AgeGroups:C0001792	aged adult (elderly; 65-80 years)
T130	AgeGroup	6684	6706	75-years-old and under	AgeGroups:C0683973	middle aged adult (45-64 years)
T131	AgeGroup	6684	6706	75-years-old and under	AgeGroups:C0001675	adult (19-44 years)
T132	AgeGroup	6684	6706	75-years-old and under	AgeGroups:C0238598	young adult (19-24 years)
T133	AgeGroup	6684	6706	75-years-old and under	AgeGroups:C0205653	adolescent (13-18 years)
T134	AgeGroup	6684	6706	75-years-old and under	AgeGroups:C0008059	children (6-12 years)
T135	AgeGroup	6684	6706	75-years-old and under	AgeGroups:C0008100	preschool children (2-5 years)
T137	AgeGroup	6684	6706	75-years-old and under	AgeGroups:C0021289	newborn
T136	AgeGroup	6684	6706	75-years-old and under	AgeGroups:C0021270	infant
T139	AgeGroup	6721	6735	older than 75 	AgeGroups:C0001795	adult, aged over 80 (>80 years)
T140	AgeGroup	6721	6735	older than 75 	AgeGroups:C0001792	aged adult (elderly; 65-80 years)
T138	Phenotype	6744	6747	MTA	null	null
T141	Phenotype	6801	6804	MTA	null	null
T142	Phenotype	6833	6836	WMH	UMLS:C2938912	White matter hyperintensities
T143	Phenotype	7088	7091	WMH	UMLS:C2938912	White matter hyperintensities
T145	Phenotype	7159	7186	white matter hyperintensity	UMLS:C2938912	White matter hyperintensities
T144	Phenotype	7192	7195	WMH	UMLS:C2938912	White matter hyperintensities
T146	Phenotype	7301	7304	WMH	UMLS:C2938912	White matter hyperintensities
T147	Phenotype	7327	7330	WMH	UMLS:C2938912	White matter hyperintensities
T148	Phenotype	7414	7417	WMH	UMLS:C2938912	White matter hyperintensities
T149	Phenotype	7469	7472	WMH	UMLS:C2938912	White matter hyperintensities
T150	Phenotype	7552	7555	WMH	UMLS:C2938912	White matter hyperintensities
T151	Phenotype	7586	7589	WMH	UMLS:C2938912	White matter hyperintensities
T152	Phenotype	7716	7719	MTA	null	null
T153	Phenotype	7724	7727	WMH	UMLS:C2938912	White matter hyperintensities
T154	Phenotype	7914	7917	MTA	null	null
T155	Phenotype	7968	7971	WMH	UMLS:C2938912	White matter hyperintensities
T156	Phenotype	8608	8611	MTA	null	null
T33	Phenotype	8616	8619	WMH	UMLS:C2938912	White matter hyperintensities
T158	Phenotype	8671	8674	WMH	UMLS:C2938912	White matter hyperintensities
T159	Phenotype	8679	8682	MTA	null	null
T160	Drug	8774	8799	cholinesterase inhibitors	UMLS:C0008425	Cholinesterase Inhibitors
T161	Measure	8919	8923	TMSE	null	null
T162	Measure	9184	9188	TMSE	null	null
T64	Disease	9348	9372	very mild to moderate AD	UMLS:C0002395	Alzheimer's Disease
T163	Gender	9324	9329	women	Gender:C0015780	female
T164	Gender	9338	9341	men	Gender:C0086582	male
T165	Measure	9588	9592	TMSE	null	null
T166	Measure	9630	9633	CDR	UMLS:C0451074	Clinical dementia rating scale
T182	Measure	10663	10667	TMSE	null	null
T183	Measure	10754	10758	TMSE	null	null
T184	Measure	10810	10814	TMSE	null	null
T185	Measure	10902	10906	TMSE	null	null
T186	Phenotype	10991	10994	WMH	UMLS:C2938912	White matter hyperintensities
T187	Phenotype	11023	11026	WMH	UMLS:C2938912	White matter hyperintensities
T188	Phenotype	11206	11209	WMH	UMLS:C2938912	White matter hyperintensities
T363	Phenotype	11547	11550	WMH	UMLS:C2938912	White matter hyperintensities
T23	Drug	11725	11729	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T189	Phenotype	11657	11660	MTA	null	null
T190	Measure	11675	11679	TMSE	null	null
T191	Measure	11814	11818	TMSE	null	null
T192	Phenotype	11880	11883	MTA	null	null
T193	Phenotype	11970	11973	MTA	null	null
T6	Drug	12820	12849	ChEI cholinesterase inhibitor	UMLS:C0008425	Cholinesterase Inhibitors
T24	Drug	12278	12290	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T25	Drug	12760	12772	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T194	Measure	12147	12151	TMSE	null	null
T195	Phenotype	12202	12205	MTA	null	null
T196	Measure	12245	12249	TMSE	null	null
T197	Measure	12379	12383	TMSE	null	null
T198	ScaleMax	12414	12425	more than 2	null	null
T199	AgeGroup	12506	12527	60-years old or older	AgeGroups:C0683973	middle aged adult (45-64 years)
T200	AgeGroup	12506	12527	60-years old or older	AgeGroups:C0001792	aged adult (elderly; 65-80 years)
T201	AgeGroup	12506	12527	60-years old or older	AgeGroups:C0001795	adult, aged over 80 (>80 years)
T202	AgeGroup	12585	12610	younger than 60-years old	AgeGroups:C0683973	middle aged adult (45-64 years)
T203	AgeGroup	12585	12610	younger than 60-years old	AgeGroups:C0001675	adult (19-44 years)
T204	AgeGroup	12585	12610	younger than 60-years old	AgeGroups:C0238598	young adult (19-24 years)
T205	AgeGroup	12585	12610	younger than 60-years old	AgeGroups:C0205653	adolescent (13-18 years)
T206	AgeGroup	12585	12610	younger than 60-years old	AgeGroups:C0008059	children (6-12 years)
T207	AgeGroup	12585	12610	younger than 60-years old	AgeGroups:C0008100	preschool children (2-5 years)
T208	AgeGroup	12585	12610	younger than 60-years old	AgeGroups:C0021270	infant
T209	AgeGroup	12585	12610	younger than 60-years old	AgeGroups:C0021289	newborn
T210	Phenotype	12662	12665	MTA	null	null
T211	AgeGroup	12724	12745	60-years old or older	AgeGroups:C0683973	middle aged adult (45-64 years)
T212	AgeGroup	12724	12745	60-years old or older	AgeGroups:C0001792	aged adult (elderly; 65-80 years)
T213	AgeGroup	12724	12745	60-years old or older	AgeGroups:C0001795	adult, aged over 80 (>80 years)
T214	Measure	12774	12818	TMSE Taiwanese Mini-Mental State Examination	null	null
T26	Drug	13102	13106	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T215	Measure	12954	12958	TMSE	null	null
T216	Measure	13154	13158	TMSE	null	null
T217	Measure	13160	13163	CDR	UMLS:C0451074	Clinical dementia rating scale
T218	Phenotype	13171	13174	MTA	null	null
T219	Phenotype	13192	13195	WMH	UMLS:C2938912	White matter hyperintensities
T27	Drug	13239	13243	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T28	Drug	13351	13363	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T220	AgeGroup	13203	13214	Younger age	null	null
T221	Phenotype	13274	13277	MTA	null	null
T222	Measure	13330	13334	TMSE	null	null
T223	Phenotype	13385	13388	WMH	UMLS:C2938912	White matter hyperintensities
T224	Measure	13429	13433	TMSE	null	null
T240	Measure	14288	14292	TMSE	null	null
T241	AgeGroup	14459	14479	60-years old or less	AgeGroups:C0683973	middle aged adult (45-64 years)
T242	AgeGroup	14459	14479	60-years old or less	AgeGroups:C0001675	adult (19-44 years)
T243	AgeGroup	14459	14479	60-years old or less	AgeGroups:C0238598	young adult (19-24 years)
T244	AgeGroup	14459	14479	60-years old or less	AgeGroups:C0205653	adolescent (13-18 years)
T245	AgeGroup	14459	14479	60-years old or less	AgeGroups:C0008059	children (6-12 years)
T246	AgeGroup	14459	14479	60-years old or less	AgeGroups:C0008100	preschool children (2-5 years)
T247	AgeGroup	14459	14479	60-years old or less	AgeGroups:C0021270	infant
T248	AgeGroup	14459	14479	60-years old or less	AgeGroups:C0021289	newborn
T249	AgeGroup	14491	14510	older than 60 years	AgeGroups:C0683973	middle aged adult (45-64 years)
T250	AgeGroup	14491	14510	older than 60 years	AgeGroups:C0001792	aged adult (elderly; 65-80 years)
T251	AgeGroup	14491	14510	older than 60 years	AgeGroups:C0001795	adult, aged over 80 (>80 years)
T252	Phenotype	14643	14646	WMH	UMLS:C2938912	White matter hyperintensities
T253	Phenotype	14651	14654	MTA	null	null
T254	Phenotype	14718	14721	WMH	UMLS:C2938912	White matter hyperintensities
T255	AgeGroup	14791	14825	younger or older than 60-years old	AgeGroups:C0021289	newborn
T256	AgeGroup	14791	14825	younger or older than 60-years old	AgeGroups:C0021270	infant
T257	AgeGroup	14791	14825	younger or older than 60-years old	AgeGroups:C0008100	preschool children (2-5 years)
T258	AgeGroup	14791	14825	younger or older than 60-years old	AgeGroups:C0008059	children (6-12 years)
T259	AgeGroup	14791	14825	younger or older than 60-years old	AgeGroups:C0205653	adolescent (13-18 years)
T260	AgeGroup	14791	14825	younger or older than 60-years old	AgeGroups:C0238598	young adult (19-24 years)
T261	AgeGroup	14791	14825	younger or older than 60-years old	AgeGroups:C0001675	adult (19-44 years)
T262	AgeGroup	14791	14825	younger or older than 60-years old	AgeGroups:C0683973	middle aged adult (45-64 years)
T263	AgeGroup	14791	14825	younger or older than 60-years old	AgeGroups:C0001792	aged adult (elderly; 65-80 years)
T264	AgeGroup	14791	14825	younger or older than 60-years old	AgeGroups:C0001795	adult, aged over 80 (>80 years)
T265	Phenotype	14858	14861	MTA	null	null
T266	AgeGroup	14974	14995	60-years old or older	AgeGroups:C0683973	middle aged adult (45-64 years)
T267	AgeGroup	14974	14995	60-years old or older	AgeGroups:C0001792	aged adult (elderly; 65-80 years)
T268	AgeGroup	14974	14995	60-years old or older	AgeGroups:C0001795	adult, aged over 80 (>80 years)
T269	Phenotype	15085	15088	MTA	null	null
T270	Phenotype	15175	15178	MTA	null	null
T271	AgeGroup	15209	15216	younger	null	null
T4	Drug	15740	15769	ChEI cholinesterase inhibitor	UMLS:C0008425	Cholinesterase Inhibitors
T29	Drug	15585	15597	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T272	AgeGroup	15318	15341	60-years old or younger	AgeGroups:C0683973	middle aged adult (45-64 years)
T273	AgeGroup	15318	15341	60-years old or younger	AgeGroups:C0001675	adult (19-44 years)
T274	AgeGroup	15318	15341	60-years old or younger	AgeGroups:C0238598	young adult (19-24 years)
T275	AgeGroup	15318	15341	60-years old or younger	AgeGroups:C0205653	adolescent (13-18 years)
T276	AgeGroup	15318	15341	60-years old or younger	AgeGroups:C0008059	children (6-12 years)
T277	AgeGroup	15318	15341	60-years old or younger	AgeGroups:C0008100	preschool children (2-5 years)
T278	AgeGroup	15318	15341	60-years old or younger	AgeGroups:C0021270	infant
T279	AgeGroup	15318	15341	60-years old or younger	AgeGroups:C0021289	newborn
T280	Phenotype	15410	15413	MTA	null	null
T281	Phenotype	15474	15477	MTA	null	null
T282	Measure	15484	15488	TMSE	null	null
T283	Measure	15649	15653	TMSE	null	null
T284	Measure	15694	15738	TMSE Taiwanese Mini-Mental State Examination	null	null
T285	AgeGroup	15612	15631	60 years or younger	AgeGroups:C0021289	newborn
T286	AgeGroup	15612	15631	60 years or younger	AgeGroups:C0021270	infant
T287	AgeGroup	15612	15631	60 years or younger	AgeGroups:C0008100	preschool children (2-5 years)
T288	AgeGroup	15612	15631	60 years or younger	AgeGroups:C0008059	children (6-12 years)
T289	AgeGroup	15612	15631	60 years or younger	AgeGroups:C0205653	adolescent (13-18 years)
T290	AgeGroup	15612	15631	60 years or younger	AgeGroups:C0238598	young adult (19-24 years)
T291	AgeGroup	15612	15631	60 years or younger	AgeGroups:C0001675	adult (19-44 years)
T292	AgeGroup	15612	15631	60 years or younger	AgeGroups:C0683973	middle aged adult (45-64 years)
T293	Phenotype	15849	15852	MTA	null	null
T294	Phenotype	15868	15871	WMH	UMLS:C2938912	White matter hyperintensities
T295	Measure	16052	16055	CDR	UMLS:C0451074	Clinical dementia rating scale
T296	Measure	16066	16070	TMSE	null	null
T297	Phenotype	16082	16085	WMH	UMLS:C2938912	White matter hyperintensities
T298	Phenotype	16101	16104	MTA	null	null
T299	Phenotype	16141	16144	WMH	UMLS:C2938912	White matter hyperintensities
T300	Measure	16188	16192	TMSE	null	null
T301	Phenotype	16228	16231	MTA	null	null
T302	AgeGroup	16271	16280	older age	null	null
T303	Phenotype	16310	16313	MTA	null	null
T304	Measure	16356	16359	CDR	UMLS:C0451074	Clinical dementia rating scale
T305	Phenotype	16413	16416	WMH	UMLS:C2938912	White matter hyperintensities
T306	Phenotype	16510	16513	WMH	UMLS:C2938912	White matter hyperintensities
T307	Phenotype	16518	16521	MTA	null	null
T386	Disease	16560	16572	hypertension	UMLS:C0020538	Hypertensive disease
T387	Disease	16584	16601	diabetes mellitus	UMLS:C0011849	Diabetes Mellitus
T388	Disease	16613	16627	hyperlipidemia	UMLS:C0020473	Hyperlipidemia
T389	Disease	16643	16666	obstructive sleep apnea	UMLS:C0520679	Sleep Apnea, Obstructive
T308	Phenotype	16915	16918	WMH	UMLS:C2938912	White matter hyperintensities
T390	AgeGroup	16790	16799	older age	null	null
T391	Disease	16844	16861	diabetes mellitus	UMLS:C0011849	Diabetes Mellitus
T335	Phenotype	17009	17012	MTA	null	null
T31	Drug	18316	18328	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T65	Disease	18203	18222	mild to moderate AD	UMLS:C0002395	Alzheimer's Disease
T316	Phenotype	18398	18401	WMH	UMLS:C2938912	White matter hyperintensities
T317	Phenotype	18522	18525	WMH	UMLS:C2938912	White matter hyperintensities
T318	Phenotype	18609	18612	WMH	UMLS:C2938912	White matter hyperintensities
T338	Phenotype	18238	18241	MTA	null	null
T339	Phenotype	18483	18486	MTA	null	null
T340	Phenotype	18663	18666	MTA	null	null
T368	Measure	18350	18354	TMSE	null	null
T369	Measure	18580	18584	TMSE	null	null
T370	Measure	18436	18440	TMSE	null	null
T383	Measure	18694	18697	CDR	UMLS:C0451074	Clinical dementia rating scale
T396	AgeGroup	18255	18264	older age	null	null
T397	AgeGroup	18639	18648	older age	null	null
T32	Drug	18965	18979	ChEI treatment	UMLS:C0008425	Cholinesterase Inhibitors
T319	Phenotype	18785	18788	WMH	UMLS:C2938912	White matter hyperintensities
T341	Phenotype	18777	18780	MTA	null	null
T371	Measure	18906	18910	TMSE	null	null
T372	Measure	19131	19135	TMSE	null	null
T33	Drug	19574	19586	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T398	Phenotype	19437	19465	medial temporal lobe atrophy	null	null
T399	Phenotype	19467	19486	hippocampal atrophy	UMLS:C3280737	Hippocampal atrophy (1 patient)
T400	Phenotype	19492	19518	entorhinal cortex thinning	null	null
T66	AgeGroup	20083	20088	older	null	null
T67	Disease	20119	20121	AD	UMLS:C0002395	Alzheimer's Disease
T342	Phenotype	20057	20060	MTA	null	null
T68	Disease	20266	20268	AD	UMLS:C0002395	Alzheimer's Disease
T69	Disease	20508	20510	AD	UMLS:C0002395	Alzheimer's Disease
T343	Phenotype	20429	20432	MTA	null	null
T344	Phenotype	20582	20595	prominent MTA	null	null
T345	Phenotype	20602	20605	MTA	null	null
T346	Phenotype	20668	20671	MTA	null	null
T347	AgeGroup	20642	20656	older than 75 	AgeGroups:C0001792	aged adult (elderly; 65-80 years)
T348	AgeGroup	20642	20656	older than 75 	AgeGroups:C0001795	adult, aged over 80 (>80 years)
T401	AgeGroup	20706	20729	75 years old or younger	AgeGroups:C0021289	newborn
T402	AgeGroup	20706	20729	75 years old or younger	AgeGroups:C0021270	infant
T403	AgeGroup	20706	20729	75 years old or younger	AgeGroups:C0008100	preschool children (2-5 years)
T404	AgeGroup	20706	20729	75 years old or younger	AgeGroups:C0008059	children (6-12 years)
T405	AgeGroup	20706	20729	75 years old or younger	AgeGroups:C0205653	adolescent (13-18 years)
T406	AgeGroup	20706	20729	75 years old or younger	AgeGroups:C0238598	young adult (19-24 years)
T407	AgeGroup	20706	20729	75 years old or younger	AgeGroups:C0001675	adult (19-44 years)
T408	AgeGroup	20706	20729	75 years old or younger	AgeGroups:C0683973	middle aged adult (45-64 years)
T409	AgeGroup	20706	20729	75 years old or younger	AgeGroups:C0001792	aged adult (elderly; 65-80 years)
T410	AgeGroup	20706	20729	75 years old or younger	AgeGroups:C0001795	adult, aged over 80 (>80 years)
T34	Drug	20879	20893	ChEI treatment	UMLS:C0008425	Cholinesterase Inhibitors
T349	Phenotype	20777	20790	prominent MTA	null	null
T373	Measure	20840	20844	TMSE	null	null
T350	Phenotype	21013	21016	MTA	null	null
T374	Measure	21057	21061	TMSE	null	null
T35	Drug	21154	21166	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T70	Disease	21171	21173	AD	UMLS:C0002395	Alzheimer's Disease
T351	Phenotype	21078	21081	MTA	null	null
T411	Phenotype	21095	21114	white matter change	UMLS:C1833300	White matter changes
T36	Drug	21363	21375	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T412	Disease	21263	21275	hypertension	UMLS:C0020538	Hypertensive disease
T413	Phenotype	21280	21300	white matter lesions	UMLS:C2752009	White matter lesion
T37	Drug	21521	21533	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T320	Phenotype	21475	21478	WMH	UMLS:C2938912	White matter hyperintensities
T38	Drug	21898	21910	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T414	Phenotype	21639	21667	subcortical hyperintensities	null	null
T39	Drug	22084	22088	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T321	Phenotype	22076	22079	WMH	UMLS:C2938912	White matter hyperintensities
T375	Measure	22128	22132	TMSE	null	null
T322	Phenotype	22209	22212	WMH	UMLS:C2938912	White matter hyperintensities
T415	Phenotype	22170	22196	global white matter lesion	UMLS:C2752009	White matter lesion
T71	Disease	22321	22323	AD	UMLS:C0002395	Alzheimer's Disease
T416	Phenotype	22329	22349	white matter changes	UMLS:C1833300	White matter changes
T417	Phenotype	22369	22388	subcortical changes	null	null
T429	Phenotype	22417	22442	neurodegenerative process	HPO:HP:0002180	Neurodegeneration
T323	Phenotype	22637	22640	WMH	UMLS:C2938912	White matter hyperintensities
T324	Phenotype	22932	22935	WMH	UMLS:C2938912	White matter hyperintensities
T352	Phenotype	22645	22648	MTA	null	null
T419	AgeGroup	22855	22862	old age	null	null
T420	Disease	22665	22677	hypertension	UMLS:C0020538	Hypertensive disease
T421	Disease	22679	22693	hyperlipidemia	UMLS:C0020473	Hyperlipidemia
T422	Disease	22695	22712	diabetes mellitus	UMLS:C0011849	Diabetes Mellitus
T423	Disease	22723	22746	obstructive sleep apnea	UMLS:C0520679	Sleep Apnea, Obstructive
T424	Disease	22864	22881	diabetes mellitus	UMLS:C0011849	Diabetes Mellitus
T325	Phenotype	23051	23054	WMH	UMLS:C2938912	White matter hyperintensities
T425	Phenotype	22989	23015	global white matter change	UMLS:C1833300	White matter changes
T326	Phenotype	23377	23380	WMH	UMLS:C2938912	White matter hyperintensities
T353	Phenotype	23326	23329	MTA	null	null
T376	Measure	23447	23451	TMSE	null	null
T327	Phenotype	23472	23475	WMH	UMLS:C2938912	White matter hyperintensities
T354	Phenotype	23481	23484	MTA	null	null
T377	Measure	23509	23513	TMSE	null	null
T384	Measure	23518	23521	CDR	UMLS:C0451074	Clinical dementia rating scale
T328	Phenotype	23611	23614	WMH	UMLS:C2938912	White matter hyperintensities
T355	Phenotype	23603	23606	MTA	null	null
T426	Phenotype	23557	23582	neurodegenerative process	HPO:HP:0002180	Neurodegeneration
T356	Phenotype	23688	23691	MTA	null	null
T72	Disease	23801	23803	AD	UMLS:C0002395	Alzheimer's Disease
T427	Disease	23793	23796	MCI	UMLS:C1270972	Mild cognitive disorder
T73	Disease	24044	24046	AD	UMLS:C0002395	Alzheimer's Disease
T357	Phenotype	24189	24192	MTA	null	null
T428	Phenotype	24281	24298	neurodegenerative	HPO:HP:0002180	Neurodegeneration
T378	Measure	24730	24734	TMSE	null	null
T379	Measure	24767	24771	TMSE	null	null
T40	Drug	24969	24981	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T41	Drug	24867	24879	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T380	Measure	25001	25005	TMSE	null	null
T430	Demographic	24927	24933	Taiwan	UMLS:C0039260	Taiwan
T431	Phenotype	25144	25161	cognitive decline	HPO:HP:0001268	Mental deterioration
T74	Disease	25246	25264	early stages of AD	UMLS:C0002395	Alzheimer's Disease
T42	Drug	25396	25400	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T43	Drug	25350	25354	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T432	Drug	25553	25558	ChEIs	UMLS:C0008425	Cholinesterase Inhibitors
T433	Drug	25601	25606	ChEIs	UMLS:C0008425	Cholinesterase Inhibitors
T44	Drug	25666	25670	ChEI	UMLS:C0008425	Cholinesterase Inhibitors
T329	Phenotype	25797	25800	WMH	UMLS:C2938912	White matter hyperintensities
T358	Phenotype	25789	25792	MTA	null	null
T330	Phenotype	25938	25941	WMH	UMLS:C2938912	White matter hyperintensities
T359	Phenotype	26072	26075	MTA	null	null
T360	Phenotype	26065	26068	WHM	UMLS:C2938912	White matter hyperintensities
T361	Phenotype	26131	26134	MTA	null	null
T381	Measure	26215	26219	TMSE	null	null
T385	Measure	26221	26224	CDR	UMLS:C0451074	Clinical dementia rating scale
T331	Phenotype	26331	26334	WMH	UMLS:C2938912	White matter hyperintensities
T332	Phenotype	26603	26606	WMH	UMLS:C2938912	White matter hyperintensities
T45	Drug	26735	26747	ChEI therapy	UMLS:C0008425	Cholinesterase Inhibitors
T333	Phenotype	26661	26664	WMH	UMLS:C2938912	White matter hyperintensities
T52	Disease	26914	26951	mild to moderate Alzheimer’s dementia	UMLS:C0002395	Alzheimer's Disease
T362	Phenotype	26806	26809	MTA	null	null
T434	Drug	26873	26895	cholinesterase therapy	UMLS:C0008425	Cholinesterase Inhibitors
T435	Phenotype	27001	27021	white matter disease	UMLS:C2830584	White matter disease, unspecified
T334	Phenotype	27251	27254	WMH	UMLS:C2938912	White matter hyperintensities
T53	Disease	27480	27500	Alzheimer’s dementia	UMLS:C0002395	Alzheimer's Disease
T436	Phenotype	27373	27393	white matter disease	UMLS:C2830584	White matter disease, unspecified
R1	hasScale	3622	3652	Measure	3660	3663	ScaleMin
R2	hasScale	3622	3652	Measure	3666	3667	ScaleMax
R3	hasScale	12379	12383	Measure	12414	12425	ScaleMax
